AGP Executive Report
Last update: 9 hours agoEU Health: Arrowhead Pharmaceuticals won European Commission marketing authorization for REDEMPLO® (plozasiran), the first siRNA medicine approved in the EU for adults with familial chylomicronemia syndrome, aiming to cut triglycerides and enable earlier treatment without genetic testing. Denmark Tech & Security: Danish pharma Novo Nordisk says FulcrumSec spent two months inside its networks and stole about 1.3TB, including drug research, clinical trial data and AI models, after the company refused a $25m extortion demand. Nordic Policy & AI in Schools: Norway is moving ahead with a ban on generative AI for children in grades 1–7 during school hours, citing concerns about cognitive shortcutting as test scores fall. Arctic Defense: Canada plans to buy a CAN$2.5bn over-the-horizon radar system to strengthen Arctic surveillance and early warning. EV Investment (Africa): Spiro secured an extra $55m from NewTrails Capital, bringing its latest round to $270m to expand battery-swapping and EV infrastructure across Africa. EU Diplomacy: The EU and Moldova concluded their second summit, backing Moldova’s accession path and deeper security cooperation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
